-
What is NetApp?
30 Aug 2024 01:44 GMT
… professional colleagues at now-defunct Auspex Systems, an early Network Appliance … and led NetApp to its initial public offering of stock in November 1995 …
-
PureTech Announces Annual Results for Year Ended December 31, 2023
25 Apr 2024 09:33 GMT
… in multiple biotech companies, including Auspex Pharmaceuticals Inc., which was acquired by … , 2021, Vor closed its initial public offering (the "IPO") of 9,828 … prior to the Parent’s initial public offering (“IPO”) on the London Stock Exchange …
-
NetApp: NAS pioneer well set for the cloud revolution
20 Oct 2023 12:29 GMT
… in 1995, and had its initial public offering in 1995. It grew massively … early competitor to NetApp was Auspex Systems, which introduced the first … NAS filer, and by 2003, Auspex had become defunct and Network …
-
Capstan Therapeutics Appoints Justin Thacker as Chief Financial Officer and Jeffrey Pepe, J.D., Ph.D., as General Counsel
22 Mar 2023 11:54 GMT
… the company’s $276 million initial public offering. Before that, he was … the company’s $150 million initial public offering and finance infrastructure build-out … roles at ACADIA Pharmaceuticals Inc., Auspex Pharmaceuticals, Inc. and Cadence Pharmaceuticals, …
-
Erasca Announces Key Leadership Team Appointments and Recruits World-Class Research and Development Advisory Board
22 Aug 2019 14:29 GMT
… prepared the company for its initial public offering. At Annexon, Mr. Yeung served … at multiple companies, including Organovo, Auspex Pharmaceuticals, Minnow Medical and HealthFusion, assisting …
-
In a remote work world, it’s time to move past VPN
13 Oct 2020 08:37 GMT
… President of Marketing at DocuSign (IPO), the global leader in eSignature … ), BayStone (acquired by Remedy) and Auspex (IPO).
-
Biopharma Hit The Bottom. Expectations Are High For This Year
19 Apr 2017 18:20 GMT
… be a conspicuous player, while initial public offering (IPO) could provide it that last … saw 102 IPOs, 71 of which were biotechs, including Auspex Pharmaceuticals, Sage Therapeutics …
-
Tilray: A Bubble That Keeps Inflating
20 Sep 2018 15:08 GMT
… among strong IPO performers. Below is a table showing IPOs (from … at least 250% from their IPO price. For example, AnaptysBio … GWPH 2013 367% 1626% Auspex Pharmaceuticals ASPX 2014 337% 742% … subsequent performance of these top IPOs has been pretty mixed. …
About
© 1995-2025